Christopher S. Carlin

426 total citations
8 papers, 296 citations indexed

About

Christopher S. Carlin is a scholar working on Dermatology, Immunology and Periodontics. According to data from OpenAlex, Christopher S. Carlin has authored 8 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Dermatology, 5 papers in Immunology and 2 papers in Periodontics. Recurrent topics in Christopher S. Carlin's work include Psoriasis: Treatment and Pathogenesis (3 papers), Dermatology and Skin Diseases (3 papers) and Acne and Rosacea Treatments and Effects (2 papers). Christopher S. Carlin is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (3 papers), Dermatology and Skin Diseases (3 papers) and Acne and Rosacea Treatments and Effects (2 papers). Christopher S. Carlin collaborates with scholars based in United States. Christopher S. Carlin's co-authors include Alan Menter, Gerald G. Krueger, James G. Krueger, Steven R. Feldman, Gerald G. Krueger, Kristina P. Callis, Barbara B. Knowles, Scott R. Florell, Bernice R. Krafchik and Lawrence F. Eichenfield and has published in prestigious journals such as The Journal of Immunology, Experimental Cell Research and Journal of the American Academy of Dermatology.

In The Last Decade

Christopher S. Carlin

8 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher S. Carlin United States 6 230 146 52 34 34 8 296
Stephanie Mehlis United States 6 253 1.1× 151 1.0× 49 0.9× 25 0.7× 53 1.6× 14 310
A. Galluccio Italy 9 188 0.8× 153 1.0× 64 1.2× 23 0.7× 29 0.9× 11 265
JC Prinz Germany 10 372 1.6× 182 1.2× 82 1.6× 23 0.7× 68 2.0× 10 442
André Vicente Esteves de Carvalho Brazil 12 222 1.0× 133 0.9× 26 0.5× 32 0.9× 30 0.9× 34 319
Pille Konno Estonia 5 273 1.2× 218 1.5× 74 1.4× 16 0.5× 45 1.3× 5 359
Ya‐Chu Tsai Taiwan 10 229 1.0× 182 1.2× 50 1.0× 40 1.2× 42 1.2× 16 376
M. Ruer‐Mulard France 7 376 1.6× 288 2.0× 68 1.3× 24 0.7× 73 2.1× 18 522
Gaia Moretta Italy 12 275 1.2× 244 1.7× 42 0.8× 24 0.7× 39 1.1× 34 401
Mauro Bavetta Italy 11 307 1.3× 202 1.4× 95 1.8× 31 0.9× 49 1.4× 32 402
M. Viguier France 7 185 0.8× 144 1.0× 37 0.7× 11 0.3× 37 1.1× 12 247

Countries citing papers authored by Christopher S. Carlin

Since Specialization
Citations

This map shows the geographic impact of Christopher S. Carlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Carlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Carlin more than expected).

Fields of papers citing papers by Christopher S. Carlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Carlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Carlin. The network helps show where Christopher S. Carlin may publish in the future.

Co-authorship network of co-authors of Christopher S. Carlin

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Carlin. A scholar is included among the top collaborators of Christopher S. Carlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Carlin. Christopher S. Carlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Krueger, Gerald G., Lawrence F. Eichenfield, J. John Goodman, et al.. (2007). Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis.. PubMed. 6(2). 185–93. 23 indexed citations
3.
Carlin, Christopher S., Steven R. Feldman, James G. Krueger, Alan Menter, & Gerald G. Krueger. (2004). A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. Journal of the American Academy of Dermatology. 50(6). 859–866. 212 indexed citations
4.
Carlin, Christopher S.. (2004). A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis*1. Journal of the American Academy of Dermatology. 50(6). 859–866. 10 indexed citations
5.
Carlin, Christopher S., Kristina P. Callis, & Gerald G. Krueger. (2003). Efficacy of Acitretin and Commercial Tanning Bed Therapy for Psoriasis. Archives of Dermatology. 139(4). 436–42. 26 indexed citations
6.
Carlin, Christopher S., Scott R. Florell, & Gerald G. Krueger. (2002). Induction of dramatic hyperpigmentation in a patient with generalized lichen planus treated with re-PUVA. Journal of Cutaneous Medicine and Surgery. 6(2). 125–127. 6 indexed citations
7.
Carlin, Christopher S., Scott R. Florell, & Gerald G. Krueger. (2002). Induction of Dramatic Hyperpigmentation in a Patient with Generalized Lichen Planus Treated with Re-PUVA. Journal of Cutaneous Medicine and Surgery. 6(2). 125–127. 5 indexed citations
8.
Carlin, Christopher S. & Barbara B. Knowles. (1983). Identification of a 90 000-dalton cell surface glycoprotein with elevated expression in human hepatoma cells. Experimental Cell Research. 147(2). 359–367. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026